4basebio (4BB)

Sector:

Pharma and Biotech

Index:

FTSE AIM All-Share

 530.00p
   
  • Change Today:
      0.000p
  • 52 Week High: 790.00
  • 52 Week Low: 440.83
  • Currency: UK Pounds
  • Shares Issued: 15.54m
  • Volume: 0
  • Market Cap: £82.35m
  • Beta: 0.00

Latest Deals

Traded Action Notifier PriceAmountValue
20-May-26 Buy Amy Walker 509.00p 1,863 £9,482.67
13-Feb-26 Buy Amy Walker 586.08p 2,650 £15,531.12
10-Feb-26 Buy Hansjörg Plaggemars 585.00p 1,000 £5,850.00
10-Feb-26 Buy Heikki Lanckriet 575.82p 3,000 £17,274.60

Largest Deals (365 days)

Traded Action Notifier PriceAmountValue
10-Feb-26 Buy Heikki Lanckriet 575.82p 3,000 £17,274.60
13-Feb-26 Buy Amy Walker 586.08p 2,650 £15,531.12
20-May-26 Buy Amy Walker 509.00p 1,863 £9,482.67
10-Feb-26 Buy Hansjörg Plaggemars 585.00p 1,000 £5,850.00

Director Shareholdings

Notifier Holding Value*
Heikki Lanckriet 1,122,688 £5,950,246
Amy Walker 48,529 £257,204
Hansjörg Plaggemars 7,667 £40,635

Major Shareholders

Notifier** Holding Value*
Wilhelm K. T. Zours 5,119,743 £27,134,638
DELPHI Unternehmensberatung AG 5,119,743 £27,134,638
4bb AG 5,115,852 £27,114,016
M&G Plc 4,627,741 £24,527,027
Elevage Medical Technologies Holdings 4,627,741 £24,527,027
Deutsche Balaton AG 4,432,637 £23,492,976
2invest AG 2,229,083 £11,814,140
Sparta AG 1,351,718 £7,164,105
Latonba AG 778,891 £4,128,122
Franciscus De Busschere 537,255 £2,847,452

* Value is calculated by using the current share price multiplied by the amount held.
** Major Shareholders are individuals or institutions that own more than 3% of the company’s shares and have been reported in the annual accounts.

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

 

4basebio Market Data

Currency UK Pounds
Share Price 530.00p
Change Today 0.000p
% Change 0.00 %
52 Week High 790.00
52 Week Low 440.83
Volume 0
Shares Issued 15.54m
Market Cap £82.35m
Beta 0.00

4basebio Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
36.54% below the market average36.54% below the market average36.54% below the market average36.54% below the market average36.54% below the market average
12.20% above the sector average12.20% above the sector average12.20% above the sector average12.20% above the sector average12.20% above the sector average
Price Trend
85.18% below the market average85.18% below the market average85.18% below the market average85.18% below the market average85.18% below the market average
53.49% below the sector average53.49% below the sector average53.49% below the sector average53.49% below the sector average53.49% below the sector average
Income Not Available
Growth
61.98% above the market average61.98% above the market average61.98% above the market average61.98% above the market average61.98% above the market average
92.86% above the sector average92.86% above the sector average92.86% above the sector average92.86% above the sector average92.86% above the sector average

4basebio Dividends

No dividends found

Trades for --2026

Time Volume / Share Price
0 @ 0.000p

4basebio Key Personnel

CFO David John Roth
CEO Amy Walker
COO Scott Lorimer

Top of Page